Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 322

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 322
---
 the launch of numerous FDA-approved esoteric tests, as well as several new laboratory developed
tests. Dr. Krenitsky served as Chief Executive Officer at both BioServe Biotechnologies, a global biotechnology company specializing
in processing genetic diagnostic tests, and Parkway Clinical Laboratories, a clinical diagnostic lab providing comprehensive routine
and esoteric testing. He also held various senior-level positions within Genomics Collaborative, Inc. (a SeraCare Life Sciences Company),
a full-scale clinical and genomics research company, and is a former Board member of the New York State Clinical Lab Association and
BioServe. Dr. Krenitsky received a B.S. in business management from the University of Scranton and an M.D. from Jefferson Medical College
(now the Sidney Kimmel Medical College) in Philadelphia.

<div align='center'>172

MANAGEMENT FOLLOWING MERGER</div>

Immediately following the Merger, the Combined Company board of directors
will be composed of five (5) members, two (2) of whom certain members of DiamiR’s management will designate and three
(3) of whom Aptorum will designate. Aptorum will appoint the following DiamiR designees: Kira Sheinerman, PhD, MBA, [ ],
and the following Aptorum designees: Ian Huen, Justin Wu, and Douglas Arner to the board of directors of the Combined Company. Ian Huen
is expected to be appointed as Chair of the Board of the Combined Company. Alidad Mireskandari, PhD, MBA will be appointed as a non-voting
observer to the Board of the Combined Company. The current staggered structure of the Aptorum Board will adjust to a single class of directors
for the Combined Company following the completion of the Merger.

The following table lists names,
ages and positions of the individuals who are expected to serve as executive officers and directors of the Combined Company following
completion of the DiamiR Merger.

| Name                |     | Age |     | Position                                    |
| Executive Officers  |     |     |     |                                             |
| Ian Huen            |     |  45 |     | Chief Executive Officer and Director        |
| Gary Anthony        |     |  63 |     | Chief Financial Officer                     |
| Alidad Mireskandari |     |  57 |     | President, Chief Operation Officer          |
| Directors           |     |     |     |                                             |
| Kira Sheinerman     |     |